Biocon Q2 profit surges on Equillium stake sale
after close1 source ↓written by the desknot a recommendation
- for the quarter
- ₹3.55 billion
- a year earlier
- ₹688 million
Biocon Ltd reported a five-fold increase in Q2 profit, reaching ₹3.55 billion for the quarter ending 30 Sept 2023, up from ₹688 million a year earlier. This surge was driven by a one-off gain of ₹1.89 billion from the sale of its stake in Equillium.
This significant profit boost may enhance investor sentiment and support Biocon's stock performance in the near term.
Not investment advice. For informational purposes only.